Tough Time To Trade Biotech Stocks, Is the Momentum Market Easing?…Update-4 ABT Rapid Test!
We took profits on many longs and shorts in the coronavirus sector so I will need to look at new trades for Q4. Our small longs for now are ABT, AZT, GNMK, GILD, MRNA, MRK, OSUR and TDOC. However We are also long many large caps in addition to above: ABBV, BMY, JNJ, RHHBY. XBI has dropped a...
Biotech Momentum Stalled: Headwinds Remain for August.Update-3 Flattish week with healthcare lagging
August 15..Update -3…Momentum slows to a walk but XBI holds the $110 handle. XLV flat at $107 level, IBB down 0.86% to $133.30. Coronavirus stocks still within 10% of 52 week highs: HOLX,REGN; weak 2020 momentum: CEMI, INO. Vaccine stock leaders: NVAX, MRNA. Gov to purchase 100M doses...
Speculative Rally in Biotech Today, Is the Correction Over Already? Update-1
Update-1 Aug 6 Coronavirus Stocks Get Hit in Profit Taking Mode-Vaccine Stocks are Weak Momentum continues to ebb : XBI down 0.51% to $113.81, red screen day. Virus high fliers take a hit: BNTX down 5.19%, GNMK down 13.965, INO down 6.7%, QDEL down 5.5%. TDOC recovered after merger with Livigno...
Biotech Traders Will Face Strong Headwinds…Update-4 BIG Tech Rules!
Update-4 Early am trading shows weakness in COVID vaccine stocks ; Investors are focused on BIG TECH.XBI down 2% to $109 level. Vaccines require constant feeding with news flow: AZN BNTX INO MRNA NVAX all in the red. Merck (MRK) up 1% on earnings, vaacines and antiviral development (Ridgeback...
Biotech Portfolio Review: What to do Next? Update-4 Vaccine Stocks Weak
Update-4 JY 23 Midday trading: Reiterate-take Profits on COVID Vaccine stocks Big Sell-Off Today: BNTX, INO, MRNA, NVAX. Antiviral stocks REGN VIR holding up. Review and update after the close. XBI weak but holding in channel. Update-3 July 21 Momentum is easing a bit with some buying into...